The IASLC 2026 World Conference on Lung Cancer (WCLC) will deliver a new wave of data on several facets of the lung cancer paradigm. Novel findings on modalities such as antibody drug conjugates, targetable mutations in markers like HER2, and other relevant therapeutic areas may pose implications for all corners of thoracic oncology.
